Chemoradiotherapy versus triplet chemotherapy as initial therapy for T4b esophageal cancer: survival results from a multicenter randomized Phase 2 trial
Makoto Yamasaki, Hiroshi Miyata, Kotaro Yamashita, Takuya Hamakawa, Koji Tanaka, Keijiro Sugimura, Tomoki Makino, Atsushi Takeno, Osamu Shiraishi, Masaaki Motoori, Yutaka Kimura, Motohiro Hirao, Kazumasa Fujitani, Takusi Yasuda, Masahiko Yano, Hidetoshi Eguchi, Yuichiro� Doki
Topics & Concepts
MedicineClinical endpointEsophageal cancerChemoradiotherapyInternal medicineRandomized controlled trialChemotherapyMulticenter trialSurvival rateSurgeryOncologyCancerMulticenter studyEsophageal Cancer Research and TreatmentCancer Immunotherapy and BiomarkersGastrointestinal Tumor Research and Treatment